CA
NZ
UK
AU
IND
US
…
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public disclosures for AVVAA World Health Care Products Inc are limited; it is an OTC Pink-listed company that identifies as a maker/distributor of health-care products but provides few details on operations or audited financials. Sector drivers such as aging populations and rising health spending could support demand for health products, which may make a small supplier attractive if it secures scale and regulatory approvals.
Key risks are opaque disclosure, very low liquidity as an OTC Pink stock, execution and regulatory risk, and a high likelihood of dilution.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2013-05-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2013-05-31 |
| Income before tax | -0.04M | -0.04M | -0.08M | -0.03M | 0.02M |
| Net income | -0.04M | -0.04M | -0.08M | -0.03M | 0.02M |
| Selling general administrative | - | - | - | - | 0.01M |
| Gross profit | 0.00M | - | -0.01M | - | 0.03M |
| Ebit | - | - | - | - | 0.02M |
| Ebitda | -0.03M | -0.04M | -0.08M | -0.03M | - |
| Operating income | -0.03M | -0.04M | -0.08M | -0.03M | 0.02M |
| Other operating expenses | 0.04M | 0.04M | 0.08M | 0.03M | - |
| Interest expense | 0.00M | - | - | - | 0.00M |
| Income tax expense | - | - | - | - | 0.00M |
| Total revenue | 0.00M | - | 0.00M | - | 0.03M |
| Total operating expenses | 0.04M | 0.04M | 0.08M | 0.03M | 0.00M |
| Cost of revenue | 0.00M | - | 0.01M | - | 0.00M |
| Total other income expense net | -0.00M | - | - | - | - |
| Net income from continuing ops | - | - | - | - | 0.02M |
| Net income applicable to common shares | - | - | - | - | 0.02M |
| Breakdown | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2013-05-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-05-31 | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2013-05-31 |
| Total assets | 0.24M | - | - | 0.27M | 0.10M |
| Intangible assets | - | - | - | - | 0.08M |
| Total liab | 0.28M | - | - | 0.09M | 13.08M |
| Total stockholder equity | -0.04M | - | - | 0.18M | -12.98M |
| Other current liab | 0.02M | - | - | 0.09M | 0.07M |
| Common stock | 0.97M | - | - | 0.97M | 1.88M |
| Retained earnings | -25.85M | - | - | -30.93M | -30.91M |
| Cash | 0.01M | - | - | 0.13M | 0.00M |
| Total current liabilities | 0.03M | - | - | 0.09M | 13.08M |
| Net debt | 0.24M | - | - | -0.13M | - |
| Short term debt | - | - | - | - | 5.92M |
| Short long term debt | - | - | - | - | 5.92M |
| Short long term debt total | 0.25M | - | - | - | - |
| Other stockholder equity | 24.82M | - | - | 29.98M | 0.36M |
| Total current assets | 0.23M | - | - | 0.13M | 0.03M |
| Net tangible assets | - | - | - | - | -13.05M |
| Net receivables | - | - | - | - | 0.03M |
| Inventory | 0.22M | - | - | - | - |
| Accounts payable | 0.02M | - | - | - | 7.09M |
| Accumulated other comprehensive income | - | - | - | 0.15M | - |
| Non currrent assets other | 0.01M | - | - | 0.15M | - |
| Non current assets total | 0.01M | - | - | 0.15M | - |
| Breakdown | 2025-05-31 | 2013-05-31 | 2012-05-31 | 2011-05-31 | 2010-05-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-05-31 | 2013-05-31 | 2012-05-31 | 2011-05-31 | 2010-05-31 |
| Change to liabilities | - | 0.00M | 0.03M | -0.08M | 0.21M |
| Total cashflows from investing activities | - | -0.08M | -0.08M | -0.08M | - |
| Net borrowings | - | - | - | 0.09M | 0.24M |
| Total cash from financing activities | 0.25M | -0.00M | -0.00M | 0.09M | 0.24M |
| Change to operating activities | - | - | - | 0.00M | 0.45M |
| Net income | -0.04M | 0.02M | -0.04M | 2.21M | 2.72M |
| Change in cash | -0.00M | -0.00M | 0.00M | -0.03M | 0.03M |
| Begin period cash flow | 0.01M | - | - | - | - |
| End period cash flow | 0.01M | - | - | - | - |
| Total cash from operating activities | -0.25M | 0.08M | 0.00M | -0.12M | -0.21M |
| Depreciation | - | 0.20M | 0.00M | 0.00M | 0.00M |
| Change to inventory | -0.22M | - | - | - | - |
| Change to account receivables | - | -0.03M | 0.01M | -0.00M | -0.00M |
| Sale purchase of stock | - | 0.02M | 0.02M | 0.02M | - |
| Other cashflows from financing activities | -0.00M | - | - | - | - |
| Change to netincome | - | -0.12M | -0.12M | -2.26M | -3.60M |
| Capital expenditures | 0.00M | 0.08M | 0.08M | 0.08M | 0.00M |
| Change in working capital | -0.21M | - | - | - | - |
| Free cash flow | -0.25M | - | - | - | - |
Sector: Financial Services Industry: Mortgage Finance
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AVVH AVVAA World Health Care Products Inc |
- -% |
0.00 | - | - | 74.85 | - | 0.40 | -0.02 |
| FMCCT Federal Home Loan Mortgage Corp Pref Perpetual |
0.19 1.64% |
11.79 | 197.79 | - | 2.68 | - | - | - |
| RKT Rocket Companies Inc |
0.88 7.38% |
12.80 | 8.17 | 62.50 | 7.58 | 3.14 | - | - |
| FNMFO Federal National Mortgage Association |
- -% |
25000.00 | 1000000.00 | - | 0.55 | - | - | - |
| FNMAS Federal National Mortgage Association Pref S |
0.18 2.30% |
7.99 | 1701.43 | - | 0.55 | - | - | - |
AVVAA World Health Care Products, Inc. provides natural and therapeutic skin care products worldwide. The company is a biotechnology company which primarily focuses on manufacturing and marketing over-the-counter the Neuroskin line of products used for the treatment of skin abnormalities, and to enhance the natural clarity and texture of healthy skin through mass marketing food and drug channels. It also has distribution rights for patented European skin care products, which are scientifically developed to treat the symptoms of skin diseases, including eczema, psoriasis, and acne. The company also offers a line of natural animal care products, which is a grooming treatment for dogs, cats, horses, and other pets. AVVAA World Health Care Products, Inc. was incorporated in 1998 and is based in Richmond, Virginia. As of June 23, 2021, AVVAA World Health Care Products, Inc. operates as a subsidiary of Gold Quest Capital, Inc.
7400 Beaufont Springs Drive, Richmond, VA, United States, 23225
866 864 6598
5
| Name | Title | Year Born |
|---|---|---|
| Mr. Jason Price | CEO, COO & Director | NA |
| Dr. Stephanie Willet | Interim Pres, Treasurer, Sec. & Director | NA |
| Mr. James Haney | VP of Manufacturing & Distribution and Manufacturing & Distribution Consultant | 1936 |
| Dr. Jerry A. Moore | Science & Regularity Consultant | NA |
| Dr. Stephanie Willet | Interim President, Treasurer, Secretary & Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...